Systemic therapy in cervical cancer: 30 years in review
M Liontos, A Kyriazoglou, I Dimitriadis… - Critical reviews in …, 2019 - Elsevier
Advanced-inoperable cervical cancer is a challenging entity due to increased percentage of
locoregional and distant recurrences. Furthermore, recurrent cervical cancer not amenable …
locoregional and distant recurrences. Furthermore, recurrent cervical cancer not amenable …
Cisplatin: an old drug with a newfound efficacy–from mechanisms of action to cytotoxicity
Introduction: Cisplatin is a highly effective antineoplastic drug with an extremely current
mechanism of action. Cisplatin-induced side effects are dose-dependent and limit the …
mechanism of action. Cisplatin-induced side effects are dose-dependent and limit the …
Role of surgical versus clinical staging in Chemoradiated FIGO stage IIB-IVA cervical cancer patients—acute toxicity and treatment quality of the uterus-11 Multicenter …
S Marnitz, P Martus, C Köhler, C Stromberger… - International Journal of …, 2016 - Elsevier
Purpose The Uterus-11 trial was designed to evaluate the role of surgical staging in patients
with cervical cancer before primary chemoradiation therapy (CRT). The present report …
with cervical cancer before primary chemoradiation therapy (CRT). The present report …
[HTML][HTML] Long-term survival following neoadjuvant chemotherapy and concomitant radiochemotherapy in locally advanced cervical cancer: results of the Oncology …
A Marita, C Ordeanu, A Rancea, T Nicolae… - Journal of Medicine …, 2018 - ncbi.nlm.nih.gov
Objective: to analyze the efficiency of (NACT) followed by concurrent radiochemotherapy
(RCT) in patients with locally advanced cervical cancer, 5-year overall, specific and disease …
(RCT) in patients with locally advanced cervical cancer, 5-year overall, specific and disease …
Weekly versus triweekly cisplatin-based concurrent chemoradiotherapy in the treatment of locally advanced cervical carcinoma: An updated meta-analysis based on …
J Zhu, Z Zhang, D Bian, Q Chen, Q Hu, S Ji, K Gu - Medicine, 2020 - journals.lww.com
Background: Radiotherapy concurrent with cisplatin is the standard regimen used for
treatment of locally advanced cervical carcinoma. In this meta-analysis, survival, recurrence …
treatment of locally advanced cervical carcinoma. In this meta-analysis, survival, recurrence …
Weekly vs. tri-weekly cisplatin based chemoradiation in carcinoma cervix: a prospective randomized study of toxicity and compliance
A Katke, R Nanda, B Thejaswini… - reports of practical …, 2021 - journals.viamedica.pl
Background: Addition of chemotherapy to radiation has improved 5-year survival by 6%.
However, the optimal dose and schedule of concurrent cisplatin is not well defined, though …
However, the optimal dose and schedule of concurrent cisplatin is not well defined, though …
Concurrent weekly cisplatin versus triweekly cisplatin with radiotherapy for locally advanced squamous-cell carcinoma of the cervix: a retrospective analysis from a …
Y Kinjyo, Y Nagai, T Toita, W Kudaka… - The British Journal of …, 2017 - academic.oup.com
Objective: To compare patients with cervical cancer who were primarily treated with
concurrent chemoradiotherapy (CCRT) using 20 mg m− 2 CDDP for 5 days every 3 weeks …
concurrent chemoradiotherapy (CCRT) using 20 mg m− 2 CDDP for 5 days every 3 weeks …
Concurrent weekly single cisplatin vs triweekly cisplatin alone with radiotherapy for treatment of locally advanced cervical cancer: a meta-analysis
J Zhu, S Ji, Q Hu, Q Chen, Z Liu, J Wu… - Cancer Management and …, 2018 - Taylor & Francis
Background Radiotherapy (RT) concurrent with cisplatin (CDDP) is the standard regimen
used for treatment of locally advanced cervical carcinoma. In this meta-analysis, we …
used for treatment of locally advanced cervical carcinoma. In this meta-analysis, we …
Local experience in cervical cancer imaging: Comparison in tumour assessment between TRUS and MRI
C Ordeanu, DC Pop, R Badea… - Reports of Practical …, 2015 - journals.viamedica.pl
Objective The aim of study was to analyze the accuracy of TRUS (transrectal ultrasound) vs.
MRI (magnetic resonance imaging) and clinical gynecological examination estimation in the …
MRI (magnetic resonance imaging) and clinical gynecological examination estimation in the …
Ten years survival results of randomized study comparing weekly vs. triweekly cisplatin with concurrent radiation in locally advanced carcinoma cervix
R Nanda, A Katke, B Thejaswini… - Reports of Practical …, 2023 - journals.viamedica.pl
Background: The current standard of treatment for locally advanced cervical cancer is
concurrent chemo-radiation with improved overall survival (OS) by 6% with manageable …
concurrent chemo-radiation with improved overall survival (OS) by 6% with manageable …